| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |